New Drugs FDA Approves Prophylactic Treatment with Vonvendi [von Willebrand Factor (Recombinant)] for Adult Patients Living with Severe Type 3 von Willebrand Disease (VWD) 3 years ago
Pharma Industry News Pfizer’s Lorviqua receives EC approval for treatment of advanced lung cancer 3 years ago
Pharma Industry News Gene genies: Oxford Biomedica and Homology Medicines create AAV business 3 years ago